Windlas Biotech (NSE:WINDLAS) Days Sales Outstanding : 72.60 (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Windlas Biotech Days Sales Outstanding?

Windlas Biotech's average Accounts Receivable for the three months ended in Mar. 2024 was ₹1,363 Mil. Windlas Biotech's Revenue for the three months ended in Mar. 2024 was ₹1,713 Mil. Hence, Windlas Biotech's Days Sales Outstanding for the three months ended in Mar. 2024 was 72.60.

The historical rank and industry rank for Windlas Biotech's Days Sales Outstanding or its related term are showing as below:

NSE:WINDLAS' s Days Sales Outstanding Range Over the Past 10 Years
Min: 61.31 Med: 73.52 Max: 80.97
Current: 73.38

During the past 6 years, Windlas Biotech's highest Days Sales Outstanding was 80.97. The lowest was 61.31. And the median was 73.52.

NSE:WINDLAS's Days Sales Outstanding is ranked worse than
51.66% of 995 companies
in the Drug Manufacturers industry
Industry Median: 71.56 vs NSE:WINDLAS: 73.38

Windlas Biotech's Days Sales Outstanding declined from Mar. 2023 (75.78) to Mar. 2024 (72.60).

Windlas Biotech Days Sales Outstanding Historical Data

The historical data trend for Windlas Biotech's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Windlas Biotech Days Sales Outstanding Chart

Windlas Biotech Annual Data

Trend

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Days Sales Outstanding

Get a 7-Day Free Trial

69.83

61.31

74.90

80.97

73.22

Windlas Biotech Quarterly Data
	Mar19	Mar20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Days Sales Outstanding	Get a 7-Day Free Trial												75.78	73.65	76.15	71.67	72.60

Competitive Comparison of Windlas Biotech's Days Sales Outstanding

For the Drug Manufacturers - Specialty & Generic subindustry, Windlas Biotech's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Windlas Biotech's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Windlas Biotech's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Windlas Biotech's Days Sales Outstanding falls into.

Windlas Biotech Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Windlas Biotech's Days Sales Outstanding for the fiscal year that ended in Mar. 2024 is calculated as

	Days Sales Outstanding (A: Mar. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Mar. 2023 )	+	Accounts Receivable (A: Mar. 2024 ))	/	count )	/	Revenue (A: Mar. 2024 )	*	Days in Period
=	( (1168.6	+	1362.77)	/	2 )	/	6309.56	*	365
=	1265.685					/	6309.56	*	365
=	73.22

Windlas Biotech's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

	Days Sales Outstanding (Q: Mar. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2023 )	+	Accounts Receivable (A: Mar. 2024 ))	/	count )	/	Revenue (A: Mar. 2024 )	*	Days in Period
=	( (0	+	1362.77)	/	1 )	/	1712.85	*	365 / 4
=	1362.77					/	1712.85	*	365 / 4
=	72.60

Windlas Biotech (NSE:WINDLAS) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Windlas Biotech Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Windlas Biotech's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Windlas Biotech (NSE:WINDLAS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Windlas Biotech Ltd (NSE:WINDLAS) » Definitions » Days Sales Outstanding

Traded in Other Exchanges

543329:India

Address

Golf Course Extension Road, 705-706, Vatika Professional Point, Sector-66, Gurgaon, HR, IND, 122 001

Website

https://www.windlas.com

Windlas Biotech Ltd is a pharmaceutical formulations contract development and manufacturing organization. The company offers a range of CDMO services from product discovery to product development, licensing, and commercial manufacturing of generic products including complex generics.

Windlas Biotech (NSE:WINDLAS) Headlines

No Headlines